The development of antiretroviral drugs for HIV has dramatically reduced disease burden for millions of people with access to adequate treatment and prevention programs. However, UNAIDS reports that 25 million people in Sub-Saharan Africa are still living with HIV, accounting for more than two-thirds of the infected population worldwide, and that women (aged 15-24) in this region are disproportionately impacted. Importantly, the number of young women at the cusp of this age range is currently very high, placing us at an important juncture. Without adequate intervention and a reduction in the rate of new infections, the most likely outcome is a resurgence of the HIV epidemic.
The scientific community must develop new and effective prevention strategies to reduce HIV transmission in order to prevent this devastating outcome. Taking into consideration economic, social, and cultural barriers to current HIV prevention strategies, approaches such as long-acting therapies are a promising path forward, however key questions remain before this approach can be put to use in community settings. This conference will address current scientific barriers to development of long-acting prevention methods for HIV.
Registration for this conference is FREE. Also available via webinar.